Skip to content
OpenCapital
Get started

Crinetics Pharmaceuticals CRNX EBITDA

EBITDA at other companies

Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$83.01M+14.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$161M-20.1%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
-$45.33M-2.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
——
Corcept Therapeutics logo
Corcept TherapeuticsCORT
——
United Therapeutics logo
United TherapeuticsUTHR
——

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$3.79B+21.9%

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0×0.0×
Current ratio18.6×-3.9×

Where this comes from

Calculated from Crinetics Pharmaceuticals’s reported figures.

−$140.4Mebit+
$1.2MDepreciation Depletion & Amortization
=-$139.22M

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Crinetics Pharmaceuticals's EBITDA?
Crinetics Pharmaceuticals (CRNX) reported EBITDA of -$139.22M in Q1 2026.
How has Crinetics Pharmaceuticals's EBITDA changed year-over-year?
Crinetics Pharmaceuticals's EBITDA decreased by 26.0% year-over-year, from -$110.48M to -$139.22M.
What is the long-term trend for Crinetics Pharmaceuticals's EBITDA?
Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's EBITDA has grown at a 48.0% compound annual growth rate (CAGR), from -$106.78M to -$512.88M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.